Ghatkopar (East), Mumbai)
Home >Nephrology > High-Flux Dialysis
High-Flux Dialysis in Mumbai
Superior Toxin Clearance Through High-Permeability Dialysis Membranes
Standard dialysis removes small waste molecules adequately - but the toxins that accumulate over years of kidney failure are larger, and conventional membranes simply cannot clear them efficiently. High-flux dialysis in Mumbai at Shree Hospitals uses advanced high-permeability synthetic membranes that remove a significantly broader spectrum of uremic toxins - including middle molecules like beta-2 microglobulin - that standard low-flux dialysis leaves behind. For patients on long-term dialysis, this difference in clearance translates directly into better cardiovascular outcomes, fewer complications, and a meaningfully improved quality of life.
Facing Newborn Complications? Get Immediate Neonatal Care
Quick facts
Type of Procedure: Haemodialysis using high-permeability synthetic membrane dialyser
Duration of Each Session: 3 to 4 hours per session, typically 3 sessions per week
Type of Anaesthesia: No anaesthesia required; outpatient procedure under nursing supervision
Recovery Duration: Outpatient procedure; patients return home within 30 minutes of session completion
Key Benefit: Removes middle-molecule uremic toxins including beta-2 microglobulin; reduces long-term cardiovascular risk and dialysis-related amyloidosis
Type of Insurance: Covered under major health insurance policies; some plans require prior authorisation for high-flux membrane specification
What is High-Flux Dialysis?
Not all dialysis membranes are equal. The fundamental difference between low-flux and high-flux haemodialysis treatment Mumbai India lies in the pore size of the dialyser membrane. Low-flux membranes clear small molecules - urea, creatinine, potassium - efficiently, but are largely impermeable to middle molecules with molecular weights between 500 and 60,000 Daltons. These middle molecules, particularly beta-2 microglobulin, parathyroid hormone fragments, and inflammatory cytokines, accumulate progressively in long-term dialysis patients and drive some of the most serious complications of chronic kidney failure.
High-flux dialysis uses synthetic membranes - polysulfone, polyethersulfone, or helixone - with significantly larger and more uniform pores. This allows convective transport of middle molecules across the membrane in addition to the diffusive clearance of small solutes. The result is a more complete toxin removal profile with each session.
The clinical benefits of advanced dialysis membrane therapy Mumbai are well documented in long-term outcome studies. The HEMO study and the MPO study demonstrated that high-flux dialysis reduces cardiovascular mortality, slows the progression of beta-2 microglobulin clearance dialysis-related amyloidosis, and improves patient survival compared to low-flux treatment - particularly in patients who have been on dialysis for more than three years. At Shree Hospitals, high-flux membranes are the standard of care across our dialysis programme, not an optional upgrade.
When Should You Consider High-Flux Dialysis?
High-flux dialysis is recommended when:
- Patient has been on haemodialysis for more than 12 months
- Dialysis-related amyloidosis symptoms - carpal tunnel, joint pain - are present
- Elevated beta-2 microglobulin levels on routine monitoring
- Cardiovascular risk reduction is a clinical priority
- Serum albumin is low suggesting chronic inflammatory state
- Residual renal function has been lost completely
- Transition from low-flux to superior clearance is clinically indicated
Is This Treatment Right for You?
High-flux dialysis is appropriate when:
- Established on regular three-times-weekly haemodialysis schedule
- Ultrapure dialysate water quality is confirmed at the treating centre
- Vascular access delivers adequate blood flow rates above 250 ml/min
- Nephrologist has reviewed middle molecule burden on laboratory testing
- No specific contraindication to high-permeability membrane use
- Patient understands the long-term rather than immediate benefit profile
Why Does Middle Molecule Clearance Matter?
- Small molecule clearance alone does not prevent all dialysis complications
- Beta-2 microglobulin clearance dialysis reduces amyloid deposits in joints and tendons
- Middle molecule accumulation drives chronic inflammation and cardiovascular damage
- High-flux membranes remove inflammatory cytokines reducing systemic inflammation
- Long-term survival data consistently favours high-flux over low-flux treatment
- High permeability dialysis membrane use is recommended by KDOQI and ERA-EDTA guidelines
The toxins that cause most long-term dialysis complications are too large for standard membranes to remove.
High-flux dialysis clears what conventional treatment leaves behind - and that difference accumulates with every session over years of treatment.
24×7 Emergency Care
Our Approach to High-Flux Dialysis
At Shree Hospitals, high-flux dialysis is not simply a membrane upgrade - it is part of a broader commitment to dialysis quality that includes ultrapure water treatment, individualised prescriptions, and monthly outcome monitoring. Our high-flux dialysis in Mumbai programme is built on the understanding that long-term dialysis patients deserve the best available technology at every session - not just when complications have already developed.
24×7 Emergency Care
Ultrapure Dialysate Water Standard
High-flux membranes are bidirectional - their large pores allow back-filtration of dialysate into the blood if water quality is substandard. This makes ultrapure dialysate an absolute requirement, not a preference. Our water treatment system uses multiple filtration stages including reverse osmosis and ultrafilters positioned immediately before the dialyser to achieve endotoxin levels below 0.03 EU/ml - the international ultrapure standard. Water quality is tested monthly without exception.
Membrane Selection and Prescription Integration
Different high-flux membranes have different clearance profiles. Our nephrologists select the membrane type - polysulfone, helixone, or polyethersulfone - based on each patient's middle molecule burden, albumin levels, and vascular access flow rates. Improved dialysis outcomes kidney care requires matching the membrane to the patient, not issuing the same dialyser to every person on the programme.
Middle Molecule Monitoring
Pre-dialysis beta-2 microglobulin levels are measured quarterly for all high-flux patients. PTH, phosphate, and inflammatory markers are tracked monthly. Reduction ratios for beta-2 microglobulin are calculated to confirm that the membrane and prescription are achieving adequate middle molecule clearance. Where targets are not met, session duration, blood flow rate, or membrane type is adjusted at the next monthly review.
Long-Term Complication Surveillance
Dialysis-related amyloidosis - carpal tunnel syndrome, destructive arthropathy, and bone cysts - is screened clinically at every quarterly review. Cardiovascular risk factors are managed proactively. Advanced dialysis membrane therapy Mumbai is most valuable when combined with aggressive management of blood pressure, anaemia, phosphate, and volume status - the full package of chronic kidney disease complication prevention.
Top Nephrology Specialists in Mumbai
Every haemodialysis patient at Shree Hospitals is under the care of senior consultant nephrologists with subspecialty expertise in dialysis adequacy, vascular access management, and chronic kidney disease complications. Now at Shree Hospitals, Mumbai.
24×7 Emergency Care
Dr. Siddharth Lakhani
Nephrology, Renal Transplantation, Hemodialysis & CKD Care
Dr. Gaurav Bhandari
Consultant Nephrologist and Transplant Physician in Mumbai
Advanced Dialysis Services at Shree Hospitals
High-flux dialysis services at Shree Hospitals are supported by advanced nephrology care and modern haemodialysis technology — providing enhanced removal of middle-molecule toxins, efficient fluid management, advanced dialysis monitoring, infection prevention protocols, and personalised renal care for patients requiring long-term dialysis support or complex kidney disease management.
Enhanced Toxin Clearance
Improved clearance of middle molecules such as beta-2 microglobulin, helping reduce dialysis-related complications and improving treatment effectiveness in patients receiving long-term dialysis.
Step by Step Process of High-Flux Dialysis
Step 1: Nephrology Assessment and Modality Selection
Patients transitioning to high-flux dialysis or enrolling new undergo a full nephrological review. Middle molecule burden is assessed through beta-2 microglobulin measurement. Vascular access flow rates are confirmed adequate for high-flux membrane requirements. The nephrologist documents the clinical rationale for high-flux membrane selection and sets individualised targets for small and middle molecule clearance.
Step 2: Water Quality Verification
Before any high-flux session, dialysate water quality is confirmed against ultrapure standards. The reverse osmosis system output and ultrafilter integrity are checked through routine conductivity and endotoxin testing. Any deviation from ultrapure standards results in immediate suspension of high-flux sessions until water quality is restored - back-filtration through a high-permeability membrane with contaminated water causes more harm than low-flux dialysis.
Step 3: Machine Setup with High-Flux Dialyser
The prescribed high-flux dialyser is mounted and the bloodlines primed. Dialysate composition is programmed - bicarbonate, potassium, calcium, and sodium concentrations set individually. The ultrafiltration target is calculated based on the difference between current and dry weight. Blood pump, dialysate flow rate, and treatment time are set according to the individualised prescription before vascular access is connected.
Step 4: High-Flux Dialysis Session
Blood flow rates of 250 to 350 ml per minute are maintained throughout the session. The high permeability dialysis membrane operates through a combination of diffusion and convection - small molecules clear rapidly by diffusion down concentration gradients while middle molecules are removed by convective transport driven by transmembrane pressure. The patient is monitored every 30 minutes for blood pressure, heart rate, and symptomatic tolerance.
Step 5: Post-Session Assessment and Documentation
At session completion, post-dialysis weight confirms ultrafiltration target achievement. Blood pressure and symptoms are assessed before discharge. The session is documented including any intradialytic events, blood pressure trends, and access performance. Pre and post-dialysis urea samples are taken monthly for Kt/V calculation - confirming both small molecule adequacy and treatment time efficiency.
Step 6: Quarterly Middle Molecule Review
Every three months, pre-dialysis beta-2 microglobulin is measured and reduction ratio calculated. Results are reviewed against targets - pre-dialysis beta-2 microglobulin below 27 mg/L and reduction ratio above 60% indicate adequate high-flux haemodialysis treatment Mumbai India performance. Where targets are not achieved, membrane type, blood flow rate, or session duration is adjusted. Clinical screening for amyloidosis symptoms is documented at the same appointment.
Patient Questions About High-Flux Dialysis
What are the benefits of high-flux dialysis over standard dialysis?
High-flux dialysis uses advanced membranes that remove a wider range of toxins, including larger middle molecules, helping improve dialysis efficiency, reduce toxin buildup, and support better long-term outcomes.
What are the risks and considerations of high-flux membranes?
High-flux dialysis is generally safe, but some patients may require careful monitoring for fluid balance changes, blood pressure fluctuations, and dialysis-related reactions based on their overall health condition.
What should you ask during your nephrology consultation?
Ask your nephrologist whether high-flux dialysis is suitable for your kidney condition, how it differs from standard dialysis, expected benefits, treatment frequency, and how your progress will be monitored.
How will I know if high-Flux Ddialysis Is working for me?
Improvement is assessed through dialysis adequacy tests, toxin level monitoring, symptom improvement, better fluid control, and overall changes in energy levels and quality of life.
Evidence-Based Case Studies by Our Specialists
Would Recommend Us
Seven-year dialysis patient with progressive carpal tunnel syndrome and chronic fatigue. Beta-2 microglobulin measured at 42 mg/L on low-flux programme. Switched to high-flux dialysis in Mumbai with helixone membrane. Beta-2 microglobulin fell to 24 mg/L at 6-month review. Carpal tunnel symptoms reduced significantly without surgical intervention.
Mr . Aditya . K
Diabetic nephropathy patient with high cardiovascular risk and elevated CRP on standard dialysis. Transitioned to high-flux programme with ultrapure dialysate. Inflammatory markers normalised within 3 months. Blood pressure control improved - antihypertensive dose reduced at 6-month review. Remains stable on advanced dialysis membrane therapy Mumbai at 2-year follow-up.
Mr . Ashish . K
Long-term dialysis patient approaching 10 years on renal replacement therapy. Proactively switched to high-flux protocol to reduce amyloidosis and cardiovascular risk burden. Annual joint imaging shows no progression of amyloid deposits. Beta-2 microglobulin clearance dialysis targets consistently achieved. Currently being evaluated for transplant listing.
Mr. Sachin . L
Patient
Resources
Schedule consultation
Billing & Payments
Health Packages
Hospital Facilities
24×7 Emergency Care
1800-268-4000
News & Updates
Shree Hospitals is the first to perform robotic endo surgery.
Shree Hospitals Introduces Advanced Robotic Surgery for Better Patient Care
Shree Hospitals Expands Advanced Surgical Care With Latest Medical Technology
Health Center
Exploring the Future of Telemedicine: What’s Next for Healthcare?
The Rise of Renewable Energy: Innovations in Sustainability
Follow Us
Shree
Hospitals
Shree
Hospitals
